William Plovanic
Stock Analyst at Canaccord Genuity
(3.44)
# 883
Out of 4,870 analysts
131
Total ratings
44.07%
Success rate
4.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by William Plovanic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Initiates: Buy | $35 | $30.25 | +15.70% | 1 | Jun 17, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $115 → $101 | $91.22 | +10.72% | 3 | May 12, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $152 → $139 | $145.74 | -4.62% | 10 | May 2, 2025 | |
| DXCM DexCom | Maintains: Buy | $103 → $106 | $80.00 | +32.50% | 6 | May 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $58 → $59 | $20.22 | +191.79% | 4 | May 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Hold | $71 → $75 | $73.83 | +1.58% | 26 | Apr 25, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $23 → $18 | $5.86 | +207.17% | 8 | Apr 8, 2025 | |
| TLSI TriSalus Life Sciences | Maintains: Buy | $11 | $5.61 | +96.08% | 4 | Mar 28, 2025 | |
| ATRC AtriCure | Maintains: Buy | $66 → $52 | $31.36 | +65.82% | 11 | Mar 28, 2025 | |
| TMDX TransMedics Group | Maintains: Buy | $104 | $123.56 | -15.83% | 5 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $8 | $3.45 | +131.88% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $17.91 | +84.25% | 4 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $92 → $101 | $57.87 | +74.53% | 3 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $269 → $304 | $303.15 | +0.28% | 3 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $101 | $101.30 | -0.30% | 9 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $15 | $6.54 | +129.53% | 4 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $12 | $10.02 | +19.76% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $284 | $256.87 | +10.56% | 4 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $10.95 | +128.41% | 1 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $12 | $2.62 | +358.02% | 5 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $86 → $70 | $91.98 | -23.90% | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $77 → $48 | $16.34 | +193.76% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $4.41 | +398.87% | 3 | Jul 25, 2023 |
Artivion
Jun 17, 2025
Initiates: Buy
Price Target: $35
Current: $30.25
Upside: +15.70%
Zimmer Biomet Holdings
May 12, 2025
Maintains: Hold
Price Target: $115 → $101
Current: $91.22
Upside: +10.72%
iRhythm Technologies
May 2, 2025
Maintains: Buy
Price Target: $152 → $139
Current: $145.74
Upside: -4.62%
DexCom
May 2, 2025
Maintains: Buy
Price Target: $103 → $106
Current: $80.00
Upside: +32.50%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $58 → $59
Current: $20.22
Upside: +191.79%
Edwards Lifesciences
Apr 25, 2025
Maintains: Hold
Price Target: $71 → $75
Current: $73.83
Upside: +1.58%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $5.86
Upside: +207.17%
TriSalus Life Sciences
Mar 28, 2025
Maintains: Buy
Price Target: $11
Current: $5.61
Upside: +96.08%
AtriCure
Mar 28, 2025
Maintains: Buy
Price Target: $66 → $52
Current: $31.36
Upside: +65.82%
TransMedics Group
Mar 11, 2025
Maintains: Buy
Price Target: $104
Current: $123.56
Upside: -15.83%
Mar 5, 2025
Maintains: Buy
Price Target: $5 → $8
Current: $3.45
Upside: +131.88%
Feb 26, 2025
Maintains: Buy
Price Target: $33
Current: $17.91
Upside: +84.25%
Jan 10, 2025
Maintains: Buy
Price Target: $92 → $101
Current: $57.87
Upside: +74.53%
Dec 9, 2024
Maintains: Buy
Price Target: $269 → $304
Current: $303.15
Upside: +0.28%
Dec 9, 2024
Maintains: Buy
Price Target: $98 → $101
Current: $101.30
Upside: -0.30%
Nov 6, 2024
Maintains: Buy
Price Target: $12 → $15
Current: $6.54
Upside: +129.53%
Oct 4, 2024
Maintains: Buy
Price Target: $13 → $12
Current: $10.02
Upside: +19.76%
Feb 23, 2024
Reiterates: Buy
Price Target: $284
Current: $256.87
Upside: +10.56%
Jan 22, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $10.95
Upside: +128.41%
Oct 31, 2023
Maintains: Buy
Price Target: $20 → $12
Current: $2.62
Upside: +358.02%
Aug 28, 2023
Maintains: Hold
Price Target: $86 → $70
Current: $91.98
Upside: -23.90%
Aug 3, 2023
Downgrades: Hold
Price Target: $77 → $48
Current: $16.34
Upside: +193.76%
Jul 25, 2023
Maintains: Buy
Price Target: $21 → $22
Current: $4.41
Upside: +398.87%